Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinoma

Cancer Immunol Immunother. 2004 May;53(5):445-52. doi: 10.1007/s00262-003-0490-8. Epub 2004 Feb 10.

Abstract

We have compared the effect of one and up to four local IL-2 treatments of transplanted MC38 colon carcinoma. A single IL-2 treatment prolonged the survival time ( p=0.015), but no cure was obtained. One local IL-2 treatment inhibited tumor growth for about 1 week. After the start of tumor regrowth, a further IL-2 injection was given. After four IL-2 injections 6 out of 13 mice were cured. Histological studies show that IL-2 induced a local vascular leakage syndrome leading to massive peritumoral edema and subsequent necrosis of tumor tissue. IL-2 also attracted infiltrating cells, mainly macrophages. Subsequent IL-2 injections led to complete tumor regression. We believe that the combination of necrotic tumor debris and the IL-2-induced macrophage reaction enhanced a tumor-specific immune response. This local IL-2 application was not toxic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / pathology
  • Dose-Response Relationship, Drug
  • Female
  • Interleukin-2 / administration & dosage*
  • Interleukin-2 / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Neoplasms, Experimental / drug therapy*
  • Neoplasms, Experimental / pathology
  • Nitric Oxide / metabolism
  • Tumor Cells, Cultured / transplantation

Substances

  • Interleukin-2
  • Nitric Oxide